First human test for groundbreaking lung scarring drug begins
Knowledge-focused
Recruiting now
This is a very early study to check the safety of a new experimental drug called SRN001 in healthy volunteers. The drug is designed to treat a serious lung scarring disease called idiopathic pulmonary fibrosis, but this first trial is only testing it in healthy men to see how the…
Phase: PHASE1 • Sponsor: siRNAgen Therapeutics Inc. • Aim: Knowledge-focused
Last updated Apr 15, 2026 16:14 UTC